Third-Generation Thyrotropin Receptor Antibody (TRAb) assay for predicting neonatal thyroid dysfunction in pregnant women with Graves' disease.

Autor: Priyanka R; Department of Endocrinology, Madurai Medical College & Govt. Rajaji Hospital, Madurai, 625 020, Tamil Nadu, India., Sridhar S; Department of Endocrinology, Madurai Medical College & Govt. Rajaji Hospital, Madurai, 625 020, Tamil Nadu, India. drsridharjipmer@gmail.com., Sumathi B; Department of Obstetrics and Gynecology, Madurai Medical College & Govt. Rajaji Hospital, Madurai, 625 020, Tamil Nādu, India., Jeyaraj AR; Department of Endocrinology, Madurai Medical College & Govt. Rajaji Hospital, Madurai, 625 020, Tamil Nadu, India.; Department of Neonatology, Madurai Medical College & Govt Rajaji Hospital, Madurai, India., Natarajan V; Department of Endocrinology, Madurai Medical College & Govt. Rajaji Hospital, Madurai, 625 020, Tamil Nadu, India., Subbiah E; Department of Diabetology, Madurai Medical College & Govt. Rajaji Hospital, Madurai, 625 020, Tamil Nādu, India., Raghavan KS; Department of Diabetology, Madurai Medical College & Govt. Rajaji Hospital, Madurai, 625 020, Tamil Nādu, India., Sangumani J; Dean, Government Medical College, Virudhunagar, Virudhunagar, 626001, Tamil Nādu, India.

Publikováno v: Endocrine [Endocrine] 2024 May; Vol. 84 (2), pp. 500-508. Date of Electronic Publication: 2023 Oct 20.

NetrinG1 ⁺ cancer-associated fibroblasts generate unique extracellular vesicles that support the survival of pancreatic cancer cells under nutritional stress.

Autor: Raghavan KS; Doctoral program in Molecular Cell Biology and Genetics, Drexel University College of Medicine, Philadelphia, PA, USA.; Cancer Signaling and Epigenetics Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA.; Marvin and Concetta Greenberg Pancreatic Cancer Institute, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA., Francescone R; Cancer Signaling and Epigenetics Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA.; Marvin and Concetta Greenberg Pancreatic Cancer Institute, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA., Franco-Barraza J; Cancer Signaling and Epigenetics Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA.; Marvin and Concetta Greenberg Pancreatic Cancer Institute, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA., Gardiner JC; Cancer Signaling and Epigenetics Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA.; Marvin and Concetta Greenberg Pancreatic Cancer Institute, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA., Vendramini-Costa DB; Cancer Signaling and Epigenetics Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA.; Marvin and Concetta Greenberg Pancreatic Cancer Institute, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA., Luong T; Cancer Signaling and Epigenetics Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA.; Marvin and Concetta Greenberg Pancreatic Cancer Institute, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA., Pourmandi N; Department of Molecular & Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI, USA., Andren A; Department of Molecular & Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI, USA., Kurimchak A; Cancer Signaling and Epigenetics Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA., Ogier C; Marvin and Concetta Greenberg Pancreatic Cancer Institute, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA.; Molecular Therapeutics Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA., Campbell PM; Cancer Signaling and Epigenetics Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA.; Marvin and Concetta Greenberg Pancreatic Cancer Institute, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA., Duncan JS; Cancer Signaling and Epigenetics Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA., Lyssiotis CA; Department of Molecular & Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI, USA., Languino LR; Prostate Cancer Discovery and Development Program, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA., Cukierman E; Cancer Signaling and Epigenetics Program, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA.; Marvin and Concetta Greenberg Pancreatic Cancer Institute, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA, USA.

Publikováno v: Cancer research communications [Cancer Res Commun] 2022 Sep; Vol. 2 (9), pp. 1017-1036. Date of Electronic Publication: 2022 Sep 19.

15(S)15 METHYL PGF

Autor: Alwani, Cm, Devi, Pk, Nair, Ms, T, Seetha, R, Vijaya, Raghavan, Ks

Publikováno v: Acta obstetricia et gynecologica Scandinavica. 67(S145)

A multicentre trial of Prostin 15M in second trimester abortion in 322 patients of whom 115 were primigravidae was conducted during the period of six months. Intramuscular injection of Prostin 15M 250 µg was given two hourly till one centimeter dila

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::1c6c2b3df476a21332e3f5405b8a3aa0
https://pubmed.ncbi.nlm.nih.gov/29120039

STUDIES ON 15(S)15 METHYL PGF

Autor: R, Anjaneylu, Devi, Pk, C R, Kanthamani, Rao A, Padma, Raghavan, Ks

Publikováno v: Acta obstetricia et gynecologica Scandinavica. 67(S145)

A multicentre study was undertaken to study the intramuscular 15(S)-5 methyl PGF

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::8096868724e30b172dcd7340f0c884d4
https://pubmed.ncbi.nlm.nih.gov/29120045

INDUCTION OF SECOND TRIMESTER ABORTION BY INTRAAMNIOTIC ADMINISTRATION OF 15(S)15 METHYL PGF

Autor: Bhatt, Rv, Devi, Pk, G, Dhar, Jalnawalla, Sf, M, Kochhar, Kothwani, Bg, D, Kutty, Rajan, R, Roychowdhary, Nn, Raghavan, Ks

Publikováno v: Acta obstetricia et gynecologica Scandinavica. 67(S145)

In a multicentre trial 139 women between 15 and 20 weeks of gestation were treated with 2.5 mg intraamniotic administration of 15(S)15 methyl PGF

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::72eee981c7edc803b4f9830e3046f9a5
https://pubmed.ncbi.nlm.nih.gov/29120043